The relationship between serum homocysteine levels and sudden sensorineural hearing loss: a meta-analysis

Eur Arch Otorhinolaryngol. 2023 May;280(5):2091-2097. doi: 10.1007/s00405-023-07829-w. Epub 2023 Jan 19.

Abstract

Objective: There was disagreement over the association between serum/plasma homocysteine (HCY) levels and sudden sensorineural hearing loss (SSNHL). Through the use of a meta-analysis, this study aims to determine whether there is a significant difference in serum homocysteine levels between the SSNHL group and the control group.

Design: The Cochrane Library, EMBASE, and PubMed databases were all thoroughly searched. The two independent reviewers thoroughly examined the initially searched articles. The data results were calculated by standard mean difference (SMD) or odds ratios (OR). Review Manager (version 5.3) was applied to statistical data.

Study sample: There were 766 participants in the 6 trials with continuous outcomes that were part of the meta-analysis A. In addition, meta-analysis B, which included 961 people, contained a total of 3 studies with dichotomous results.

Results: Both meta-analyses revealed the same conclusion that serum/plasma HCY levels in the SSNHL patients are higher than those in the controls (SMD 0.41, 95 % confidence interval (CI) 0.11 to 0.72, P < 0.01; OR 3.27, 95 % CI 2.16 to 4.94, P < 0.01).

Conclusion: This study demonstrated that the SSNHL patients' serum/plasma HCY levels were greater than those of the control group.

Keywords: HCY; Homocysteine; Meta-analysis; SSNHL; Sudden sensorineural hearing loss.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Databases, Factual
  • Hearing Loss, Sensorineural*
  • Hearing Loss, Sudden*
  • Homocysteine
  • Humans

Substances

  • Homocysteine